These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 32564068)

  • 1. Inflammatory Bowel Disease in the COVID-19 Pandemic: the Patients' Perspective.
    Grunert PC; Reuken PA; Stallhofer J; Teich N; Stallmach A
    J Crohns Colitis; 2020 Dec; 14(12):1702-1708. PubMed ID: 32564068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The COVID-19 Pandemic: Fears and Overprotection in Pediatric Patients with Inflammatory Bowel Disease and Their Families.
    Reinsch S; Stallmach A; Grunert PC
    Pediatr Gastroenterol Hepatol Nutr; 2021 Jan; 24(1):65-74. PubMed ID: 33505895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceptions and Attitudes Towards Medication Adherence during Pregnancy in Inflammatory Bowel Disease.
    Gallinger ZR; Rumman A; Nguyen GC
    J Crohns Colitis; 2016 Aug; 10(8):892-7. PubMed ID: 26896087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric inflammatory bowel disease and the effect of COVID-19 pandemic on treatment adherence and patients' behavior.
    Dorfman L; Nassar R; Binjamin Ohana D; Oseran I; Matar M; Shamir R; Assa A
    Pediatr Res; 2021 Sep; 90(3):637-641. PubMed ID: 33446913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 Pandemic's Effects on Disease and Psychological Outcomes of People With Inflammatory Bowel Disease in Portugal: A Preliminary Research.
    Trindade IA; Ferreira NB
    Inflamm Bowel Dis; 2021 Jul; 27(8):1224-1229. PubMed ID: 33043977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical treatment and COVID-19 related worries in patients with inflammatory bowel disease.
    Haase AM; Thorsgaard N; Lødrup AB
    Dan Med J; 2021 Feb; 68(3):. PubMed ID: 33660610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the COVID-19 surge after the end of China's Zero-COVID policy on the health-related quality of life of IBD patients.
    Wang R; Liu P; Fan C; Liu J; Jiang H; Ren J; Zhao Y; Zheng T
    BMC Gastroenterol; 2024 Sep; 24(1):312. PubMed ID: 39285342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life changes, self-prevention, knowledge and mental health among inflammatory bowel disease patients during COVID-19 pandemic: a cross-sectional study.
    He S; Xiao T; Xia Y
    Front Public Health; 2024; 12():1416880. PubMed ID: 38932786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. May you never forget what is worth remembering: the relation between recall of medical information and medication adherence in patients with inflammatory bowel disease.
    Linn AJ; van Dijk L; Smit EG; Jansen J; van Weert JC
    J Crohns Colitis; 2013 Dec; 7(11):e543-50. PubMed ID: 23660489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions and Behaviors of Patients with Inflammatory Bowel Disease during the COVID-19 Crisis.
    Lee YJ; Kim KO; Kim MC; Cho KB; Park KS; Jang BI;
    Gut Liver; 2022 Jan; 16(1):81-91. PubMed ID: 34238769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy and IBD treatment: this challenging interplay from a patients' perspective.
    Mountifield RE; Prosser R; Bampton P; Muller K; Andrews JM
    J Crohns Colitis; 2010 Jun; 4(2):176-82. PubMed ID: 21122502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Life in lockdown: experiences of patients with IBD during COVID-19.
    Harris RJ; Downey L; Smith TR; Cummings JRF; Felwick R; Gwiggner M
    BMJ Open Gastroenterol; 2020 Nov; 7(1):. PubMed ID: 33214234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease on Biological Agents During the SARS-CoV-2 Pandemic.
    Iborra I; Puig M; Marín L; Calafat M; Cañete F; Quiñones C; González-González L; Cardona G; Mañosa M; Domènech E
    Dig Dis Sci; 2021 Dec; 66(12):4191-4196. PubMed ID: 33469807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perception of the COVID-19 Pandemic Among Patients With Inflammatory Bowel Disease in the Time of Telemedicine: Cross-Sectional Questionnaire Study.
    Zingone F; Siniscalchi M; Savarino EV; Barberio B; Cingolani L; D'Incà R; De Filippo FR; Camera S; Ciacci C
    J Med Internet Res; 2020 Nov; 22(11):e19574. PubMed ID: 33006945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding attitudes, concerns, and health behaviors of patients with inflammatory bowel disease during the coronavirus disease 2019 pandemic.
    Goodsall TM; Han S; Bryant RV
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1550-1555. PubMed ID: 33063927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression, anxiety and stress among patients with inflammatory bowel disease during the COVID-19 pandemic: Australian national survey.
    Cheema M; Mitrev N; Hall L; Tiongson M; Ahlenstiel G; Kariyawasam V
    BMJ Open Gastroenterol; 2021 Feb; 8(1):. PubMed ID: 33579729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transition clinic attendance is associated with improved beliefs and attitudes toward medicine in patients with inflammatory bowel disease.
    Fu N; Jacobson K; Round A; Evans K; Qian H; Bressler B
    World J Gastroenterol; 2017 Aug; 23(29):5405-5411. PubMed ID: 28839441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covert dose reduction is a distinct type of medication non-adherence observed across all care settings in inflammatory bowel disease.
    Mountifield R; Andrews JM; Mikocka-Walus A; Bampton P
    J Crohns Colitis; 2014 Dec; 8(12):1723-9. PubMed ID: 25263934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients' real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID group.
    Nachury M; Bouhnik Y; Serrero M; Filippi J; Roblin X; Kirchgesner J; Bouguen G; Franchimont D; Savoye G; Buisson A; Louis E; Nancey S; Abitbol V; Reimund JM; DeWit O; Vuitton L; Matthieu N; Peyrin-Biroulet L; Gilletta C; Tadbiri S; Allez M; Viennot S; Bourreille A; Laharie D; Amiot A;
    Dig Liver Dis; 2021 Apr; 53(4):434-441. PubMed ID: 33187920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory bowel disease: adherence to immunomodulators in a biological therapy era.
    Campos S; Portela F; Sousa P; Sofia C
    Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1313-9. PubMed ID: 27501126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.